BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Mar 18, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-03-16

Reporting Person: Grant Stuart (SR VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-16	Common Stock	M	16615	$1.20	Acquired	31332	Direct
2011-03-16	Common Stock	S	16615	$3.39	Disposed	14717	Direct
2011-03-16	Common Stock	M	31385	$1.20	Acquired	46102	Direct
2011-03-16	Common Stock	M	17000	$1.20	Acquired	63102	Direct
2011-03-16	Common Stock	S	6000	$3.40	Disposed	57102	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-16	Emp. Stock Option (Right to Buy)	$1.20	M	16615	Disposed	2019-03-02	Common Stock (16615)	Direct
2011-03-16	Emp. Stock Option (Right to Buy)	$1.20	M	31385	Disposed	2019-03-02	Common Stock (31385)	Direct
2011-03-16	Emp. Stock Option (Right to Buy)	$1.20	M	17000	Disposed	2019-03-02	Common Stock (17000)	Direct

Footnotes

F1: These shares were transferred to the Company by the reporting person in partial payment of the exercise price of the stock options exercised on March 16, 2011.